Hager Investment Management Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Hager Investment Management Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.32M	Sell	4,669 -420	-8%	-$186K	1.07%	33
2026 Q1	$2.27M	Buy	5,089 +5	+0.1%	+$2.33K	1.25%	30
2025 Q4	$2.3M	Sell	5,084 -188	-4%	-$81K	1.26%	28
2025 Q3	$2.06M	Sell	5,272 -73	-1%	-$30.5K	1.12%	35
2025 Q2	$2.38M	Sell	5,345 -66	-1%	-$30.4K	1.42%	25
2025 Q1	$2.62M	Buy	5,411 +27	+0.5%	+$12.6K	1.83%	17
2024 Q4	$2.17M	Buy	+5,384	New	+$2.5M	1.35%	23

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Hager Investment Management Services's VRTX Position: Q2 2026 in Review

Hager Investment Management Services reduced its Vertex Pharmaceuticals (VRTX) stake by 8.3% in Q2 2026, selling an estimated $186K and leaving 4,669 shares worth $2.32M. The position accounts for 1.07% of the portfolio, ranked #33.

Hager Investment Management Services first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.62M in Q1 2025. 458 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Hager Investment Management Services held 4,669 shares of Vertex Pharmaceuticals worth $2.32M as of Q2 2026.
Hager Investment Management Services sold 420 Vertex Pharmaceuticals shares in Q2 2026, an estimated $186K.
Vertex Pharmaceuticals made up 1.07% of Hager Investment Management Services's portfolio in Q2 2026, its #33 holding.
Hager Investment Management Services first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Hager Investment Management Services's Vertex Pharmaceuticals position peaked at $2.62M in Q1 2025.
458 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Hager Investment Management Services's 13F filing for Q2 2026, filed 20 Jul 2026.